About HOOKIPA Pharma
HOOKIPA Pharma is a company based in Vienna (Austria) founded in 2011. HOOKIPA Pharma has raised $133.72 million across 7 funding rounds from investors including Gilead, FFG Austrian Research Promotion Agency and Redmile Group. The company has 87 employees as of December 31, 2024. HOOKIPA Pharma operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, Novavax and Generate Biomedicines, among others.
- Headquarter Vienna, Austria
- Employees 87 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hookipa Pharma Inc.
-
Annual Revenue
$43.95 M (USD)118.32as on Dec 31, 2024
-
Net Profit
-$43.5 M (USD)46.67as on Dec 31, 2024
-
EBITDA
-$42.03 M (USD)48.35as on Dec 31, 2024
-
Total Equity Funding
$133.72 M (USD)
in 7 rounds
-
Latest Funding Round
$21.25 M (USD), Post-IPO
Dec 20, 2023
-
Investors
Gilead
& 12 more
-
Employee Count
87
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HOOKIPA Pharma
HOOKIPA Pharma is a publicly listed company on the OTC with ticker symbol HOOK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of HOOKIPA Pharma
HOOKIPA Pharma has successfully raised a total of $133.72M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $21.25 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HOOKIPA Pharma
HOOKIPA Pharma has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Gilead, FFG Austrian Research Promotion Agency and Redmile Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Locked | Locked | Locked | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Locked | Locked | Locked |
Investor details for HOOKIPA Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HOOKIPA Pharma
Investment portfolio details for HOOKIPA Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HOOKIPA Pharma
Detailed financials for HOOKIPA Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hookipa Pharma Comparisons
Peer comparison for HOOKIPA Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HOOKIPA Pharma
HOOKIPA Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, Novavax and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| Locked | Locked | Locked |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of HOOKIPA Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hookipa Pharma
Complete news archive for HOOKIPA Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HOOKIPA Pharma
HOOKIPA Pharma was founded in 2011.
HOOKIPA Pharma is headquartered in Vienna, Austria.
HOOKIPA Pharma is a funded company, having raised a total of $133.72M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at HOOKIPA Pharma is 87.
Annual revenue of HOOKIPA Pharma is $43.95M as on Dec 31, 2024.
Developer of immunotherapies for the treatment of infectious diseases and cancer. The company uses a proprietary arenavirus platform to develop a product pipeline that inlcudes HB-201 and HB-202 for the treatment of Human Papillomavirus-16 positive (HPV16) cancers.
HOOKIPA Pharma's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Yes, HOOKIPA Pharma is publicly traded on OTC under the ticker symbol HOOK.
HOOKIPA Pharma has 13 investors. Key investors include Gilead, FFG Austrian Research Promotion Agency, Redmile Group, Samsara BioCapital, and Invus.
The ticker symbol of HOOKIPA Pharma is HOOK on OTC.